Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,330,000 | 11,464,000 | 7,514,000 | 8,372,000 | 8,995,000 |
| Marketable Securities | 340,000 | 816,000 | 171,000 | 358,000 | 274,000 |
| Receivables | 10,447,000 | 10,921,000 | 10,304,000 | 10,112,000 | 10,054,000 |
| Inventories | 2,985,000 | 2,662,000 | 2,436,000 | 2,364,000 | 2,605,000 |
| Other current assets | 5,567,000 | 5,907,000 | 7,207,000 | 6,868,000 | 5,158,000 |
| TOTAL | $28,669,000 | $31,770,000 | $27,632,000 | $28,074,000 | $27,086,000 |
| Non-Current Assets | |||||
| PPE Net | 6,750,000 | 6,646,000 | 6,481,000 | 6,355,000 | 6,279,000 |
| Investments And Advances | 367,000 | 364,000 | 325,000 | 0 | 0 |
| Intangibles | 54,498,000 | 48,241,000 | 50,097,000 | 52,466,000 | 54,731,000 |
| Other Non-Current Assets | 8,747,000 | 8,138,000 | 6,728,000 | 6,594,000 | 6,185,000 |
| TOTAL | $70,362,000 | $63,389,000 | $63,631,000 | $65,415,000 | $67,195,000 |
| Total Assets | $99,031,000 | $95,159,000 | $91,263,000 | $93,489,000 | $94,281,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,190,000 | 3,119,000 | 5,467,000 | 3,020,000 | 2,752,000 |
| Accounts payable and accrued liabilities | 3,539,000 | 3,259,000 | 2,813,000 | 3,069,000 | 3,194,000 |
| Other current liabilities | 16,093,000 | 15,884,000 | 15,182,000 | 14,061,000 | 13,139,000 |
| TOTAL | $25,822,000 | $22,262,000 | $23,462,000 | $20,150,000 | $19,085,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 49,487,000 | 36,653,000 | 32,137,000 | 34,656,000 | 35,078,000 |
| Other Non-Current Liabilities | 6,729,000 | 6,421,000 | 6,197,000 | 5,898,000 | 6,659,000 |
| TOTAL | $56,661,000 | $43,412,000 | $38,739,000 | $41,309,000 | $43,310,000 |
| Total Liabilities | $82,483,000 | $65,674,000 | $62,201,000 | $61,459,000 | $62,395,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,027,100 | 2,022,193 | 2,034,758 | 2,089,103 | 2,100,847 |
| Common Shares | 292,000 | 292,000 | 292,000 | 292,000 | 292,000 |
| Retained earnings | 15,640,000 | 28,766,000 | 28,218,000 | 27,449,000 | 26,568,000 |
| Other shareholders' equity | -1,342,000 | -1,491,000 | -1,222,000 | -1,330,000 | -1,306,000 |
| TOTAL | $16,548,000 | $29,485,000 | $29,062,000 | $32,030,000 | $31,886,000 |
| Total Liabilities And Equity | $99,031,000 | $95,159,000 | $91,263,000 | $93,489,000 | $94,281,000 |